Similarly, we observed PD-L1 upregulation in the HER2+ GBM cell lines LN229 (Supplementary Fig. S1C) and U373 (37) following treatment with IFN-γ or CART (Fig. 1D; Supplementary Fig. S1D). The gene discussed is IFNG; the disease is glioblastoma.